Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Borgohain

Showing results (291-300 of 323) with videos related to

Pageof 33
Sort By:
Neurology India|July 21, 2010
Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south IndiaDemudu Babu Boddu, V C S Srinivasarao Bandaru, Prasad G Reddy, et al.
Movement Disorders Clinical Practice|April 11, 2022
Neuroimaging Pearls from the MDS Congress Video Challenge. Part 1: Genetic DisordersDiana A Olszewska, Sapna Rawal, Conor Fearon, et al.
Movement Disorders Clinical Practice|August 31, 2024
Levodopa Equivalent Daily Dosage: Geographical Variations and Real-Life Modules in Parkinson's DiseasePrashanth Lingappa Kukkle, Lorraine V Kalia, Ahsan Habib, et al.
Scientific Reports|November 1, 2023
Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experienceVinod Metta, Rajinder K Dhamija, Lucia Batzu, et al.
Frontiers in Neurology|June 12, 2023
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical testsMubasher A Qamar, Silvia Rota, Lucia Batzu, et al.
NPJ Parkinson'S Disease|February 3, 2026
Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled studyHarini Sarva, Rajesh Pahwa, Jorge Hernandez-Vara, et al.
European Heart Journal. Cardiovascular Imaging|July 10, 2024
Artificial intelligence-based fully automated stress left ventricular ejection fraction as a prognostic marker in patients undergoing stress cardiovascular magnetic resonanceSolenn Toupin, Théo Pezel, Thomas Hovasse, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 5, 2023
A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson's disease based in United Arab EmiratesVinod Metta, Huzaifa Ibrahim, Neha Muralidharan, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 9, 2021
Clinical Study of 668 Indian Subjects with Juvenile, Young, and Early Onset Parkinson's DiseasePrashanth L Kukkle, Vinay Goyal, Thenral S Geetha, et al.
Scientific Reports|November 21, 2024
The first cross-sectional comparative observational study of sexual dysfunction in Emirati and non-Emirati Parkinson's disease patients (EmPark-SD) in the United Arab EmiratesVinod Metta, Huzaifa Ibrahim, Mubasher A Qamar, et al.
Pageof 33

Showing results (291-300 of 323) with videos related to

Sort By:
Pageof 33
Neurology India|July 21, 2010
Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south IndiaDemudu Babu Boddu, V C S Srinivasarao Bandaru, Prasad G Reddy, et al.
Movement Disorders Clinical Practice|April 11, 2022
Neuroimaging Pearls from the MDS Congress Video Challenge. Part 1: Genetic DisordersDiana A Olszewska, Sapna Rawal, Conor Fearon, et al.
Movement Disorders Clinical Practice|August 31, 2024
Levodopa Equivalent Daily Dosage: Geographical Variations and Real-Life Modules in Parkinson's DiseasePrashanth Lingappa Kukkle, Lorraine V Kalia, Ahsan Habib, et al.
Scientific Reports|November 1, 2023
Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experienceVinod Metta, Rajinder K Dhamija, Lucia Batzu, et al.
Frontiers in Neurology|June 12, 2023
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical testsMubasher A Qamar, Silvia Rota, Lucia Batzu, et al.
NPJ Parkinson'S Disease|February 3, 2026
Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled studyHarini Sarva, Rajesh Pahwa, Jorge Hernandez-Vara, et al.
European Heart Journal. Cardiovascular Imaging|July 10, 2024
Artificial intelligence-based fully automated stress left ventricular ejection fraction as a prognostic marker in patients undergoing stress cardiovascular magnetic resonanceSolenn Toupin, Théo Pezel, Thomas Hovasse, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 5, 2023
A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson's disease based in United Arab EmiratesVinod Metta, Huzaifa Ibrahim, Neha Muralidharan, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 9, 2021
Clinical Study of 668 Indian Subjects with Juvenile, Young, and Early Onset Parkinson's DiseasePrashanth L Kukkle, Vinay Goyal, Thenral S Geetha, et al.
Scientific Reports|November 21, 2024
The first cross-sectional comparative observational study of sexual dysfunction in Emirati and non-Emirati Parkinson's disease patients (EmPark-SD) in the United Arab EmiratesVinod Metta, Huzaifa Ibrahim, Mubasher A Qamar, et al.
Pageof 33